What is the recommended intravenous (IV) aminophylline loading dose and maintenance infusion rate for adults and children, and how should the regimen be adjusted in elderly patients, those with cardiac disease, hepatic or renal impairment, uncontrolled seizures, or severe arrhythmias?

Aminophylline Dosing Guidelines

Adult Intravenous Dosing

For adults with bradycardia due to second- or third-degree atrioventricular block associated with acute inferior MI, administer a 250-mg IV bolus of aminophylline. 1

Post-Heart Transplant Bradycardia

• Administer 6 mg/kg aminophylline in 100-200 mL of IV fluid over 20-30 minutes for post-heart transplant patients with symptomatic bradycardia 1
• Alternatively, use theophylline 300 mg IV, followed by oral dosing of 5-10 mg/kg/day titrated to effect 1
• Usual post-transplant dosages average 450 mg ± 100 mg/day 1
• Effective dosages often result in serum levels below the usual therapeutic range of 10-20 mcg/mL 1

Spinal Cord Injury-Related Bradycardia

• Give 6 mg/kg aminophylline in 100-200 mL of IV fluid over 20-30 minutes 1
• Follow with oral theophylline 5-10 mg/kg/day titrated to effect 1

General Adult Loading and Maintenance

• Loading dose: 4.4 mg/kg of theophylline (as aminophylline) infused over 40 minutes achieves serum levels of approximately 10 mcg/mL within 30 minutes 2
• Maintenance infusion: 1.65 mg/kg/hr of aminophylline (equivalent to 1.40 mg/kg/hr theophylline) maintains therapeutic levels around 10 mcg/mL 2
• Standard adult maintenance dosing is 0.9 mg/kg/hr when continuous monitoring is available 3

---

Pediatric Intravenous Dosing

For children with acute asthma exacerbations, the standard loading dose of 6 mg/kg aminophylline IV is frequently inadequate—72% of children develop subtherapeutic levels within 5.5 hours and 78% require additional bolus doses. 4

Loading Dose Strategy

• Initial loading dose: 6 mg/kg aminophylline IV infused over 20-30 minutes 1, 4
• For children who have NOT taken theophylline in the past 12-24 hours, use the full 6 mg/kg dose based on total body weight 5
• For children who HAVE taken theophylline within 12 hours (short-acting) or 24 hours (sustained-release), use a half dose of 3 mg/kg and obtain a pre-load theophylline level 5
• Children ≤5 years of age are more likely to have subtherapeutic concentrations and may require additional bolus doses 4
• Males are more likely than females to have subtherapeutic concentrations (67% of subtherapeutic cases were males) 4

Maintenance Infusion

• Standard maintenance: 1.0 mg/kg/hr aminophylline for children 3
• For children 1-4 years old, a maintenance dose rate of 30 mg/kg/day aminophylline (after a loading dose of 5.6 mg/kg) maintains mean steady-state plasma theophylline concentration of 10 mg/L 6
• Young children (1-4 years) have approximately 40% greater plasma theophylline clearance than adults, with a mean half-life of 3.38 hours compared to 11.02 hours in adults 6, 2

Monitoring Requirements

• Measure serum theophylline concentration within 5.5 hours of loading dose to determine need for additional bolus 4
• Target therapeutic range: 10-20 mcg/mL 1, 3, 5
• Therapeutic serum levels range from 10-20 mcg/mL 1

---

Dose Adjustments in Special Populations

Elderly Patients

• Use reduced maintenance infusion rates due to decreased drug clearance 3
• Adult clearance rates average only 0.64 ± 0.38 mL/kg/min, approximately half of previously reported values 3
• Continuous monitoring of serum theophylline concentrations is essential as clearance is highly variable 3

Cardiac Disease

• For bradycardia with hemodynamic compromise, aminophylline is reasonable as a Class IIa recommendation 1
• Monitor for potential development of ischemic chest pain when using aminophylline in cardiac patients 1
• Doses >20 mcg/kg/min of catecholamines may result in vasoconstriction or arrhythmias, though this applies to dopamine rather than aminophylline 1

Hepatic or Renal Impairment

• Significantly reduced clearance rates necessitate lower maintenance doses 3
• Variable drug clearance rates (mean 0.64 ± 0.38 mL/kg/min in adults) make it impossible to achieve optimal dosage without monitoring serum concentrations 3
• Mandatory serum theophylline monitoring before each dose adjustment 3

Uncontrolled Seizures

• Aminophylline is contraindicated or should be used with extreme caution as it can lower seizure threshold 1
• The evidence shows flumazenil reverses anticonvulsant effects of benzodiazepines and may precipitate seizures, suggesting similar caution with other CNS stimulants 1

Severe Arrhythmias

• Avoid aminophylline in patients with active tachyarrhythmias as it may worsen cardiac rhythm disturbances 1
• May cause tachycardia, bradycardia, and arrhythmias 1

---

Critical Monitoring Parameters

Serum Level Monitoring

• Initial serum theophylline concentrations vary widely and correlate poorly with drug history, making pre-load measurement essential when recent theophylline use is reported 3
• The mean change in theophylline level per mg/kg of administered aminophylline is 2.01 mcg/mL based on total body weight or 1.58 mcg/mL based on ideal body weight 5
• Neither total body weight nor ideal body weight dosing is superior—both produce similar variability 5

Clinical Monitoring

• Monitor oxygen saturation continuously 1
• Watch for signs of toxicity: nausea, vomiting, tachycardia, tremor, seizures 1
• Glucose and potassium levels should be followed during therapy 1

---

Common Pitfalls to Avoid

Dosing Errors

• Do NOT use standardized maintenance infusions without serum level monitoring—variable clearance rates produce unpredictable and often excessive concentrations 3
• Do NOT assume adequate dosing based on drug history alone—initial serum concentrations correlate poorly with reported theophylline use 3
• Do NOT rely on a single 6 mg/kg loading dose in children—most will require additional boluses 4

Administration Errors

• Infuse loading doses over 20-30 minutes minimum to avoid rapid peaks and toxicity 1, 4
• Do NOT exceed recommended infusion rates as rapid administration increases risk of cardiac effects 1

Monitoring Failures

• Do NOT initiate therapy without baseline serum theophylline level in patients reporting recent theophylline use 3, 5
• Do NOT continue maintenance infusions without serial level monitoring—clearance varies up to 10-fold between individuals 3
• In the half-dose protocol, 23.2% of patients developed toxic levels when given 3 mg/kg based on recent theophylline use 5